BRAIN-Biocatalysts Life Science Solutions
Your unique partner for flexible end-to-end enzyme development and scale-up solutions for the life science industry
Welcome to BRAIN-Biocatalysts Life Science Solutions, the result of a powerful combination of BRAIN Biotech AG’s expertise in enzyme discovery and optimisation with Biocatalysts Ltd’s commercial-scale manufacturing capabilities. We offer end-to-end enzyme solutions - from discovery and development to large-scale production - designed to meet the evolving needs of the life sciences industry. By leveraging the strengths of both companies, we simplify biocatalysis, delivering tailored, scalable solutions that ensure your product, your IP, and your future are fully supported.
End-to-end partner for enzyme solutions
At BRAIN-Biocatalysts, we specialise in delivering innovative enzyme solutions tailored for the pharmaceutical industry. Our comprehensive capabilities enable our partners to accelerate drug development, safeguard their intellectual property, and seamlessly scale from enzyme discovery to full-scale production. Whether you're developing next-generation therapies or advancing pharmaceutical processes, we're here to ensure your success at every step of the journey. By leveraging the strengths of both companies, we simplify biocatalysis, delivering tailored, scalable solutions that ensure your product, your IP, and your future are fully supported.
The only company offering complete adaptable enzyme development and scale-up solutions to support the evolving need of the life science industry
Your Product | Your IP | Your Future
Related Products
Mannitol dehydrogenase 93P
In vitro diagnostic enzyme for mannitol detection in urine as an indicator of gastric disorders.
Download Data Sheet
Request a Sample
Phenylalanine dehydrogenase 98P
Neonatal screening enzyme to perform phenylketonuria screening (PKU) test.
Download Data Sheet
Request a Sample
Proteocut K 909L
Subtilisin-type serine protease for use in variety of life science applications such as the hydrolysis of proteins in nucleic acid preparations.
Download Data Sheet
Request a Sample
Related Media
23 Jul 2024
The Crucial Role of Phenylalanine Dehydrogenase in Detecting Phenylketonuria
Phenylketonuria (PKU) is genetic disorder resulting from a deficiency in the enzyme phenylalanine hydroxylase for the conversion of the amino acid, phenylalanine to tyrosine. This condition can cause phenylalanine accumulation in the blood and result in neurological damage if left untreated or undiagnosed. Read about the highly specific and sensitive enzymatic method for early detection of PKU.
18 Nov 2022
Biocatalysts awarded in Top 10 Synthetic Biology Companies 2022 by Life Sciences Review!
We're very pleased to receive this esteemed award from Life Sciences Review in their annual listing of 10 companies that are at the forefront of providing Synthetic Biology solutions and transforming businesses.
Case Study
Developing a Cost-effective Alternative to Proteinase K
Developing an enzyme which achieves the same application performance as liquid Proteinase K at the same protein concentration.
1 Sept 2020
Biocatalysts Ltd Launch Proteocut K to the Life Science Market
The first enzyme jointly developed with BRAIN AG, is a high-quality cost-effective alternative to liquid Proteinase K.
Case Study
Development of a Polymerase for Genotyping
Scaling-up and manufacturing a customers bespoke DNA polymerase enzyme and co-development of a suitable enzyme activity assay.
Case Study
Improving a Customer's Enzyme Assay to ensure Product Viability
A robust assay that can be validated is an important part of any enzyme development process or technical transfer of an enzyme to a new manufacturing facility.
